🇺🇸 FDA
Patent

US 11267785

Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides

granted A61PA61P19/00A61P27/02

Quick answer

US patent 11267785 (Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides) held by Akebia Therapeutics, Inc. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Akebia Therapeutics, Inc.
Grant date
Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P19/00, A61P27/02, A61P35/00, A61P43/00